f-18 3f4ap
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 5, 2021 (NCT04710550)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 18-fluorine
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06999434 | Phase 1 | May 5, 2025 | National Institute on Aging (NIA), National Institutes of Health (NIH), Yale University |
| NCT04699747 | Phase 1 | Mar 25, 2021 | Harvard University |
| NCT04710550 | Phase 1 | Jan 5, 2021 | Harvard University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Harvard University | Academic/Hospital | 2 | 2 | 1 | 2021 |
| National Institute on Aging (NIA) | Government | 1 | 0 | 1 | 2025 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2025 |
| Yale University | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1